Insulet Corp Files 8-K for Material Definitive Agreement

Ticker: PODD · Form: 8-K · Filed: 2025-03-10T00:00:00.000Z

Sentiment: neutral

Topics: material-definitive-agreement, 8-k

TL;DR

Insulet just signed a big deal, details TBD.

AI Summary

On March 7, 2025, Insulet Corporation entered into a material definitive agreement. The filing does not provide specific details about the agreement, its counterparty, or any associated financial terms. The report was filed on March 10, 2025.

Why It Matters

This filing indicates a significant new contract or partnership for Insulet Corporation, which could impact its future business operations and financial performance.

Risk Assessment

Risk Level: medium — The lack of specific details in the 8-K filing creates uncertainty about the nature and implications of the material definitive agreement.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Insulet Corporation?

The filing does not specify the nature of the material definitive agreement.

Who is the counterparty to the material definitive agreement?

The filing does not disclose the identity of the other party to the agreement.

What are the key financial terms or obligations associated with this agreement?

The filing does not provide any details regarding the financial terms or obligations of the agreement.

When was the material definitive agreement officially entered into?

The material definitive agreement was entered into on March 7, 2025.

What is the purpose of this 8-K filing for Insulet Corporation?

The purpose of this 8-K filing is to report the entry into a material definitive agreement and to include financial statements and exhibits.

From the Filing

0001145197-25-000011.txt : 20250310 0001145197-25-000011.hdr.sgml : 20250310 20250310063524 ACCESSION NUMBER: 0001145197-25-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250307 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250310 DATE AS OF CHANGE: 20250310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 25722086 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 podd-20250307.htm 8-K podd-20250307 0001145197 FALSE 0001145197 2025-03-07 2025-03-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):  March 7, 2025   INSULET CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-33462 04-3523891 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 100 Nagog Park Acton Massachusetts 01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter) Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐ Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share PODD The NASDAQ Stock Market, LLC Item 1.01 – Entry into a Material Definitive Agreement. On March 7, 2025, Insulet Corporation (the “ Company ”) and NXP USA, Inc. (“ NXP ”) entered into an Addendum effective January 1, 2025 (the “ 2025 Addendum ”) to the Purchase Agreement, dated as of October 12, 2017, between the Company and NXP (the “ Original Agreement ”), as amended by an addendum entered into effective January 1, 2024 (the “ 2024 Addendum ”). Pursuant to the 2025 Addendum, which became effective January 1, 2025, the term of the Original Agreement, as amended, is extended, and certain terms and conditions related to pricing, volume, warranties, product modifications, and other matters are amended. The foregoing description of the 2025 Addendum is not intended to be complete and is qu

View on Read The Filing